Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACE X: AF Ablation vs Pharmacological Management in AF with Atrial Cardiomyopathy
NCT06200311Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2024
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Composite of cardiovascular death and first cardiovascular hospitalisation/urgent visit at 2.5 years. Started Jul 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06200311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06200311.